Table 2 Correlation between PLA2G16 expression and clinicopathological features in 130 breast cancer patients
From: A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties
| Clinicopathological features | Group | No. of patients, N = 130 (%) | p value |
|---|---|---|---|
| Age (years) | < 50 | 72 (55.4) | |
| ≥ 50 | 58 (44.6) | p = 0.255 | |
| Tumor size (cm) | < 3 | 67 (51.5) | |
| ≥ 3 | 63 (48.5) | p = 0.078 | |
| TNM stage | I–II | 70 (53.8) | |
| III–IV | 60 (46.2) | p = 0.004** | |
| Histology grade | I | 28 (21.5) | |
| II–III | 102 (78.5) | p = 0.026* | |
| Lymph node metastasis | No | 54 (41.5) | |
| Yes | 76 (58.5) | p = 0.039* | |
| Recurrence | No | 98 (75.4) | |
| Yes | 32 (24.6) | p = 0.005** |